CYTEK BIOSCIENCES, INC. Financing Receivable, Allowance for Credit Loss
CYTEK BIOSCIENCES, INC. (CTKB) had Financing Receivable, Allowance for Credit Loss of $1.23 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:FinancingReceivableAllowanceForCreditLosses · last filed 2026-08-05
- 2026-06-30: Financing Receivable, Allowance for Credit Loss $1.23M.
- 2025-12-31: Financing Receivable, Allowance for Credit Loss $729.00K.
| Period end | Financing Receivable, Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $1.23M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $729.00K 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |